← Back
Data updated: Mar 10, 2026
ALEXION PHARM
ImmunologyCardiovascularMetabolic
ALEXION PHARM is a biotechnology company focused on Immunology, Cardiovascular, Metabolic. Key products include STRENSIQ.
2007
Since
4
Drugs
-
Trials
14
Approved (2yr)
Key Drugs
Recent Activity
ULTOMIRIS 2025-09-26
Manufacturing (CMC)
SOLIRIS 2025-06-27
REMS
ULTOMIRIS 2025-06-27
REMS
SOLIRIS 2025-02-28
Efficacy
ULTOMIRIS 2025-02-28
REMS
SOLIRIS 2024-09-19
Labeling
ULTOMIRIS 2024-09-19
Labeling
KANUMA 2024-07-10
Labeling
STRENSIQ 2024-07-10
Labeling
SOLIRIS 2024-06-28
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 38%
0 drugs Phase 2: 5 Phase 1: 1
Cardiovascular 17%
0 drugs Phase 3: 1 Phase 1: 1
Metabolic 17%
0 drugs Phase 3: 1 Phase 1: 1
Respiratory 14%
0 drugs Phase 3: 1
Gastroenterology 14%
0 drugs Phase 2: 1 Phase 1: 2
Pipeline Strength Pro
Loading...
Competitors Pro
AstraZeneca big-pharma
Respiratory, Cardiovascular, Metabolic, Immunology
Novartis big-pharma
Cardiovascular, Immunology, Respiratory
Boehringer Ingelheim big-pharma
Metabolic, Respiratory, Immunology, Cardiovascular
Merck big-pharma
Cardiovascular, Immunology, Metabolic
Johnson & Johnson big-pharma
Immunology, Cardiovascular, Metabolic